It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cytokine storm induced by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a major pathological feature of Coronavirus Disease 2019 (COVID-19) and a crucial determinant in COVID-19 prognosis. Understanding the mechanism underlying the SARS-CoV-2-induced cytokine storm is critical for COVID-19 control. Here, we identify that SARS-CoV-2 ORF3a and host hypoxia-inducible factor-1α (HIF-1α) play key roles in the virus infection and pro-inflammatory responses. RNA sequencing shows that HIF-1α signaling, immune response, and metabolism pathways are dysregulated in COVID-19 patients. Clinical analyses indicate that HIF-1α production, inflammatory responses, and high mortalities occurr in elderly patients. HIF-1α and pro-inflammatory cytokines are elicited in patients and infected cells. Interestingly, SARS-CoV-2 ORF3a induces mitochondrial damage and Mito-ROS production to promote HIF-1α expression, which subsequently facilitates SARS-CoV-2 infection and cytokines production. Notably, HIF-1α also broadly promotes the infection of other viruses. Collectively, during SARS-CoV-2 infection, ORF3a induces HIF-1α, which in turn aggravates viral infection and inflammatory responses. Therefore, HIF-1α plays an important role in promoting SARS-CoV-2 infection and inducing pro-inflammatory responses to COVID-19.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Jinan University, The First Affiliated Hospital, Guangzhou, China (GRID:grid.258164.c) (ISNI:0000 0004 1790 3548); Jinan University, Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Guangzhou, China (GRID:grid.258164.c) (ISNI:0000 0004 1790 3548)
2 Huazhong University of Science and Technology, Department of Clinical Laboratory, Tongji Hospital, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223)
3 Hubei Provincial Center for Disease Control and Prevention, Wuhan, China (GRID:grid.508373.a) (ISNI:0000 0004 6055 4363)
4 Wuhan University, State Key Laboratory of Virology, College of Life Sciences, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153)
5 Wuhan University, Department of Clinical Laboratory, Renmin Hospital, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153)
6 Jinan University, Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Guangzhou, China (GRID:grid.258164.c) (ISNI:0000 0004 1790 3548)
7 Jinan University, Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Guangzhou, China (GRID:grid.258164.c) (ISNI:0000 0004 1790 3548); Foshan Institute of Medical Microbiology, Foshan, China (GRID:grid.258164.c)
8 Jinan University, The First Affiliated Hospital, Guangzhou, China (GRID:grid.258164.c) (ISNI:0000 0004 1790 3548); Jinan University, Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Guangzhou, China (GRID:grid.258164.c) (ISNI:0000 0004 1790 3548); Wuhan University, Department of Clinical Laboratory, Renmin Hospital, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153); Foshan Institute of Medical Microbiology, Foshan, China (GRID:grid.49470.3e)